Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
Federal Circuit Affirms Patent Infringement for Schizophrenia Treatment
cafc · 2025-07-08 · Plaintiff Win · Impact: 65/100
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., decided by Federal Circuit on July 8, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Teva Pharmaceutic...